Dual nk1/nk3 antagonists for treating schizophrenia

Details Dual nk1/nk3 antagonists for treating schizophrenia Dual nk1/nk3 antagonists for treating schizophrenia

C - Chemistry, Metallurgy

07

D

C07D 401/04 (2006.01) A61K 31/44 (2006.01) A61K 31/4418 (2006.01) A61K 31/4427 (2006.01) A61K 31/4439 (2006.01) A61K 31/444 (2006.01) A61K 31/46 (2006.01) A61K 31/496 (2006.01) A61K 31/4995 (2006.01) A61K 31/5377 (2006.01) A61K 31/5386 (2006.01) A61K 31/541 (2006.01) A61K 31/547 (2006.01) A61K 31/551 (2006.01) A61K 31/554 (2006.01) C07D 213/75 (2006.01)

Patent

CA 2530886

The use of compounds of the general formula wherein the substituents are as described in claim 1 or pharmaceutically active acid-addition salts thereof for the preparation of medicaments for the treatment of schizophrenia.

L'invention concerne l'utilisation des composés représentés par la formule générale (I), dont les substituants sont décrits dans la revendication 1, ou de sels d'addition d'acide pharmaceutiquement actifs de ces composés en vue de la préparation de médicaments destinés à traiter la schizophrénie.

Affiliated with

Also associated with

Rating

Dual nk1/nk3 antagonists for treating schizophrenia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dual nk1/nk3 antagonists for treating schizophrenia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dual nk1/nk3 antagonists for treating schizophrenia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1705969